Interviews with managers

Discussion in 'Acadia Pharmaceuticals' started by anonymous, Jul 19, 2020 at 6:26 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    You're both idiots. GFY
     

  2. anonymous

    anonymous Guest

    Says the guy that is still really excited about this and putting all their eggs in this basket to maybe get an offer for a product that might get approved.

    Good luck, it may end up working well for everyone if it gets approved.
     
  3. anonymous

    anonymous Guest


    Ok I see....you’re new to pharma. This study already showed serious concerns with a small number of patients enrolled. Sorry bud. Yes the FDA doesn’t approve every drug that goes through the process. I thought that was pretty well known lol.

    NUPLAZID is going to get the indication DRP just like it did for Parkinson’s.
    I win again
     
  4. anonymous

    anonymous Guest

    Not the the poster but here’s a few. And I’m one of them. Biogen was paying 135 back in 2010 for new hires. Alexion, Acorda, SK, Genentech, BMS/Celgene, Sage (but now all laid off), Novartis, if I took more time I could name more. Genentech was hiring 150’s a few years ago. Some reps Now are being paid almost 190! Not new hires but high performers. Many reps hired at 165-175. I know several people first hand. It’s all about what you make now. If your swimming in the 120 pool, take it and move to the deep end later. There’s big bucks being paid for true specialty. Not Pfizer Promoted to call on a few Cardiologist specialties. But no counterpart accountable and actually work not play 10-2 gig. Good luck.
     
  5. anonymous

    anonymous Guest

    And after reading your other posts about your Mgr friend at Biogen... they clearly don’t have much specialty experience and Biogen is their first “biotech” gig as a Mgr. Biogen has had 3 CEO’s in the last 10 years and twice as many VP of sales. The pay structure has fluctuated up and down. Soooo many companies have started paying big money that 170-175 is the new upper band. A couple years ago 150 was good but with competitive drugs companies are stealing talent and willing to pay.
     
  6. anonymous

    anonymous Guest

    Oh and all those companies I named are neuro sales forces. Not Oncology.
     
  7. anonymous

    anonymous Guest

    You are bitter and and did not get moved forward here. 120 base is really good.
     
  8. anonymous

    anonymous Guest

    I’m interviewing at Acadia and they are offering $135k and that’s very rare.
    I bet 95% of specialty Companies don’t offer that much.
    I was specialty at Abbie making $115k. I went to Teva specialty and they could only offer $120k max and I had to produce documentation of success and the last 2 years of Annual field ride evals to get $120k because they said they rarely brought people in at $120k base.

    Acadia said they base salary off of experience and it’s non-negotiable and told me they’d offer $135. I have a final interview coming up soon.
     
  9. anonymous

    anonymous Guest